What do systematic reviews say?

Behavioural activation vs any comparator

Behavioural activation showed no clear difference in treatment efficacy for depression (short term: 8–9 weeks) compared with any comparator (low certainty).

• Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
  RR 1.53 [0.98, 2.38]
  2 studies · 176 participants
  Low

Behavioural activation vs any comparator

• Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 80 participants
  Low

Behavioural activation vs any comparator

• Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 80 participants
  Low

Behavioural activation vs any comparator

Behavioural activation showed no clear difference in treatment acceptability (short term: 2 months) compared with any comparator (low certainty).

• Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
  RR 1.81 [0.68, 4.82]
  1 study · 80 participants
  Low

Behavioural activation vs any comparator

• Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 176 participants
  Low

Behavioural activation vs any comparator

• Behavioural activation therapy for depression in adults with non‐communicable diseases 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 80 participants
  Low